Will Clov announce 25% growth?
CLOV announces 25% growth and stock still goes down. Buy buy buy! the truth always wins, just look at Tesla now and it was the most shorted stock.
Is Clover Health (Clov) stock a big deal?
The fact that Clover Health was specifically called out as one of his ideas is a big deal. At least, investors in CLOV stock think so. Additionally, Clover Health has garnered interest among investors looking at the company’s potential to innovate in the health care/insurance space.
Is Clov a meme stock?
Clov is actually not a meme stock. Has revenue, stable growth no debt and Cash in hand, grossly undervalued and 2nd highest shorted stock 2x amc.
How many institutional investors own Clov stock?
As of the fourth quarter, 160 institutional investors own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) increase of 8.8%. During the period, the total amount of shares held by institutional investors also increased from 105.7 million to 129.8 million, up nearly 23% QOQ. Let’s take a look at the top five institutional shareholders.
What is going on with clover health investments?
Clover projects continuing fast growth in membership as well as operating losses for its full-year 2021 and 2022 reports. Higher member numbers would bring cost efficiencies and contribute to net earnings, which is a big mover of any stock price.
Is CLOV a buy right now?
Its 160% Revenue Growth Says Yes. By some measures Clover Health Investments (NASDAQ:CLOV) was a big deal Tuesday.
Will CLOV stock recover?
The market's direction has fueled its move from $2.62 to $3.65 per share. If the market dips from here in the short-term, CLOV stock will go down right with it. Even if you're looking at it as a long-term investment rather than a short-term trade, you may still want to take your time before buying.
Is CLOV making money?
In Q4 of 2021, Clover produced $432 million of revenue. Investors were supposed to be upbeat about the insurer's results since its revenue grew a great deal year-over-year.
Should I sell my CLOV stock?
The consensus among Wall Street research analysts is that investors should "hold" Clover Health Investments stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares.
What is prediction for CLOV stock?
The 6 analysts offering 12-month price forecasts for Clover Health Investments Corp have a median target of 3.00, with a high estimate of 7.00 and a low estimate of 2.50. The median estimate represents a +33.93% increase from the last price of 2.24.
Is CLOV undervalued?
Clover Health Investments shows a prevailing Real Value of $3.14 per share. The current price of the firm is $2.24. Based on Macroaxis valuation methodology, the firm appears to be undervalued.
Is CLOV bullish?
Clover Health Short Term - We look to Sell at 2.83 (stop at 3.09) Our outlook is bearish. We are assessed to be in a corrective mode higher. There is scope for mild buying at the open but gains should be limited.
Is CLOV pump and dump?
$CLOV The markets move literally nothing like I saw them move over the last few years... To me it is just intentionally pumping and dumping or dumping and pumping to the extreme.. And it only moves in a particular direction when the MM's want it to move...
Who owns CLOV stock?
Top 10 Owners of Clover Health Investments CorpStockholderStakeShares ownedThe Vanguard Group, Inc.6.82%25,812,040Baillie Gifford & Co.2.06%7,787,680Susquehanna Financial Group LLLP1.93%7,293,695PNC Bank, NA (Investment Manageme...1.68%6,361,4176 more rows
Will Clover Health be successful?
For full-year 2022, Clover Health offered optimistic total revenue guidance, expecting to exceed $3 billion. Medicare Advantage membership is expected to contribute to the company's success, with an anticipated 2022 average growth rate of 26% to 27% versus to the 2021 average.
What state is Clover expanding to in 2022?
With this approved service area expansion beginning January 1, 2022, Clover's Medicare Advantage (MA) plans will be available to eligible individuals in 101 new counties across Georgia, New Jersey, South Carolina, Texas, and Alabama – a new state for the company.
Is Clover Health Investments a buy right now?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last twelve months. The...
When is Clover Health Investments' next earnings date?
Clover Health Investments is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022. View our earnings forec...
How were Clover Health Investments' earnings last quarter?
Clover Health Investments, Corp. (NASDAQ:CLOV) released its quarterly earnings data on Monday, May, 9th. The company reported ($0.19) earnings per...
What guidance has Clover Health Investments issued on next quarter's earnings?
Clover Health Investments issued an update on its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share (EPS) gui...
What price target have analysts set for CLOV?
8 equities research analysts have issued 1 year price targets for Clover Health Investments' stock. Their forecasts range from $2.50 to $10.00. On...
Who are Clover Health Investments' key executives?
Clover Health Investments' management team includes the following people: Mr. Vivek Garipalli , Co-Founder, CEO & Chairman of Directors (Age 44)...
Who are some of Clover Health Investments' key competitors?
Some companies that are related to Clover Health Investments include UnitedHealth Group (UNH) , Anthem (ANTM) , Cigna (CI) , Humana (HUM) , Ce...
What is Clover Health Investments' stock symbol?
Clover Health Investments trades on the NASDAQ under the ticker symbol "CLOV."
Who are Clover Health Investments' major shareholders?
Clover Health Investments' stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group...
When is Clover Health earnings call?
What is Clover Health's 2021 earnings?
How can I listen to Clover Health Investments' earnings call? Clover Health Investments will be holding an earnings conference call on Wednesday, August 11th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.
The volatile Medicare stock is rising sharply
Clover Health Investments updated its FY 2021 earnings guidance on Wednesday, August, 18th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.40 billion-$1.50 billion, compared to the consensus revenue estimate of $811.48 million.
What happened
Matt is a Certified Financial Planner based in South Carolina who has been writing for The Motley Fool since 2012. Matt specializes in writing about bank stocks, REITs, and personal finance, but he loves any investment at the right price. Follow him on Twitter to keep up with his latest work! Follow @TMFMathGuy
So what
Clover Health ( NASDAQ:CLOV), the Medicare insurance technology company, has had a volatile history since going public through a Chamath Palihapitiya-backed SPAC, and it is on the move on Tuesday. As of 2 p.m. EDT, the stock was higher by more than 25%.
Now what
Surprisingly enough, the move is coming without any company-specific news. But recall that this isn't the first time we've seen Clover skyrocket without a good business-related reason.
WallStreetBets is trying to start another short squeeze
As mentioned, last time Clover started to rise without any news, the move lasted for about three days and resulted in the stock price more than tripling. So it's entirely possible that this move could be sustained for some time.
NASDAQ: CLOV
Earlier this year, ordinary investors on Reddit made a lot of headlines as they inspired a lot of people to buy shares in GameStop ( GME -1.52% ) and AMC Entertainment ( AMC -5.49% ). The run on the shares caused a massive short squeeze, and the two stocks skyrocketed in value almost overnight.
Premium Investing Services
Now some home traders are trying to pull off a similar feat with a healthcare company, Clover Health ( CLOV -3.21% ). Will this stock zoom higher? Or will the share price crash and burn?